Paulo Caleb Júnior Lima Santos

Author

Also Known As

Luciene C.G. Campos, P C J L Santos, P.C.J.L. Santos, Paulo C J L Santos, Paulo C. J. L. Santos, Paulo C. Santos, Paulo C.J.L. Santos, Paulo Caleb Junior Lima Santos, Paulo Caleb Júnior Lima Santos, Santos, Paulo Caleb

Publications

854

Citations

H-Index

Concepts

All Affiliations

Universidade de São Paulo Universidade Federal do Espírito Santo Universidade Federal de São Paulo Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

About

Paulo Caleb Júnior Lima Santos is an author at Universidade de São Paulo specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	195
2	Public Health	6	6	223
3	Diabetes	2	2	85
4	Engineering	1	1	27
5	Biomedical Engineering	1	1	27

Paulo Caleb Júnior Lima Santos

Publications

572

Citations

H-Index

Page 1

	Year	Citations
SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia Paulo Caleb Júnior Lima Santos, Ana Carolina Moron Gagliardi, Márcio H. Miname, European Journal of Clinical Pharmacology Lipid DisorderCardiovascular DiseaseDiabetesHyperlipidemiaDyslipidemia	2011	68
Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia Paulo Caleb Júnior Lima Santos, Aline Morgan Alvarenga, Cintia Elin Jannes, Atherosclerosis Metabolic SyndromeLipid DisorderCardiovascular DiseaseGlobal HealthGenetic Epidemiology	2014	66
Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population Rafael de Oliveira Alvim, Paulo Caleb Júnior Lima Santos, Mariane Manso Musso, Diabetology & Metabolic Syndrome	2013	66
Development of a Pharmacogenetic-Based Warfarin Dosing Algorithm and its Performance in Brazilian Patients: Highlighting the Importance of Population-Specific Calibration Paulo Caleb Júnior Lima Santos, Leiliane Rodrigues Marcatto, Núbia E. Duarte, Pharmacogenomics	2015	42
CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation Paulo Caleb Júnior Lima Santos, Carla Luana Dinardo, Isolmar Tadeu Schettert, European Journal of Clinical Pharmacology ThrombosisVenous ThrombosisCardiovascular DiseaseHematologyAnticoagulant	2012	35
Online extraction of antihypertensive drugs and their metabolites from untreated human serum samples using restricted access carbon nanotubes in a column switching liquid chromatography system Henrique Dipe de Faria, Carolina Tosin Bueno, José Eduardo Krieger, Journal of Chromatography A Online ExtractionEngineeringSeparation ScienceGas ChromatographyMedicine	2017	27
Thioredoxin interacting protein (TXNIP) rs7212 polymorphism is associated with arterial stiffness in the Brazilian general population Rafael de Oliveira Alvim, Paulo Caleb Júnior Lima Santos, Nathanne Ferreira, Journal of Human Hypertension Brazilian General PopulationCardiovascular DiseaseGeneticsPhysiologyGenetic Epidemiology	2011	25
Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation Leiliane Rodrigues Marcatto, Luciana Sacilotto, Francisco Darrieux, Oncotarget	2016	25
Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin Leiliane Rodrigues Marcatto, Luciana Sacilotto, Letícia Camargo Tavares, Frontiers in Pharmacology	2018	25
<i>CYP2C9</i> and <i>VKORC1</i> Polymorphisms Are Differently Distributed in the Brazilian Population According to Self-Declared Ethnicity or Genetic Ancestry Renata Alonso Gadi Soares, Paulo Caleb Júnior Lima Santos, George Luiz Lins Machado-Coelho, Genetic Testing and Molecular Biomarkers	2012	24

Page 1